Literature DB >> 11508811

Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping.

D Krex1, B Mohr, M Hauses, G Ehninger, H K Schackert, G Schackert.   

Abstract

To elucidate the reasons why mRNA expression of the LGI1 candidate tumor-suppressor gene was severely reduced in the glioma-derived cell line H4, as demonstrated in a previous study, we performed a cytogenetic analysis of this cell line using conventional methods and fluorescence in situ hybridization (FISH) techniques [spectral karyotyping (SKY), interphase- and chromosome FISH of metaphases (I- and C-FISH)]. Cell line H4 is monoclonal and near triploid (+/-3n). SKY enabled us to detect 24 structural aberrations: unbalanced translocations, n = 12; deletions, n = 10; insertion, n = 1; duplication, n = 1. The results were confirmed by I- and C-FISH analysis using chromosome-specific paints, centromer-specific probes and locus-specific probes for p53, PTEN/MMAC1, LGI1, Cyclin D1, EGR1, ETV6/TEL, AML1, and the genomic region 13q14.3 containing the Rb locus. We found loss of one copy of p53 as well as of one copy of Rb. Complete loss of PTEN/MMAC1 was detected, while all copies of LGI1 and Cyclin D1 were preserved. Interestingly, there was a gain of ETV6/TEL and EGR1, which were each present in quadruplicate. Additionally, the AML1 locus revealed mosaicism of cells with three and four copies, respectively. Additionally, a 5q-chromosome [del(5)(q13q33)] was found, which is one of the common features in hematological malignancies, and der(12)t(1;12) was found, suggesting that there might be an additional ETV6/TEL fusion protein. The combination of SKY, I- and C-FISH demonstrates that the neuroglioma cell line H4 harbors cytogenetic aberrations that are reported to occur in glioma-derived cell lines and additional chromosomal aberrations that have so far not been reported to occur in these cell lines. The complex aberrant karyotype and possibly generation of transcription factors by fusion proteins might be reasons for the impaired mRNA expression of the LGI1 candidate tumor-suppressor gene in cell line H4.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508811     DOI: 10.1023/a:1010680920087

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  40 in total

1.  Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme.

Authors:  V Bocchini; R Casalone; P Collini; G Rebel; F Lo Curto
Journal:  Cell Tissue Res       Date:  1991-07       Impact factor: 5.249

2.  Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells.

Authors:  V Jung; B F Romeike; W Henn; W Feiden; J R Moringlane; K D Zang; S Urbschat
Journal:  J Neuropathol Exp Neurol       Date:  1999-09       Impact factor: 3.685

3.  Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.

Authors:  C D James; E Galanis; L Frederick; D W Kimmel; J M Cunningham; P J Atherton-Skaff; J R O'Fallon; R B Jenkins; J C Buckner; S B Hunter; J J Olson; B W Scheithauer
Journal:  Int J Oncol       Date:  1999-09       Impact factor: 5.650

4.  A cytogenetic study of 53 human gliomas.

Authors:  R B Jenkins; D W Kimmel; C A Moertel; C G Schultz; B W Scheithauer; P J Kelly; G W Dewald
Journal:  Cancer Genet Cytogenet       Date:  1989-06

5.  The retinoblastoma gene is involved in malignant progression of astrocytomas.

Authors:  J W Henson; B L Schnitker; K M Correa; A von Deimling; F Fassbender; H J Xu; W F Benedict; D W Yandell; D N Louis
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

6.  A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors.

Authors:  O B Chernova; R P Somerville; J K Cowell
Journal:  Oncogene       Date:  1998-12-03       Impact factor: 9.867

7.  Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas.

Authors:  K Harada; T Nishizaki; S Ozaki; H Kubota; H Ito; K Sasaki
Journal:  Cancer Res       Date:  1998-10-15       Impact factor: 12.701

8.  Chromosomal progression of malignant human gliomas from biopsy to establishment as permanent lines in vitro.

Authors:  S H Bigner; J Mark; D D Bigner
Journal:  Cancer Genet Cytogenet       Date:  1987-01

9.  Immunohistochemistry of synapsin I and synaptophysin in human nervous system and neuroendocrine tumors. Applications in diagnostic neuro-oncology.

Authors:  T W Smith; S Nikulasson; U De Girolami; L J De Gennaro
Journal:  Clin Neuropathol       Date:  1993 Nov-Dec       Impact factor: 1.368

10.  Cytogenetics of malignant gliomas: I. The autosomes with reference to rearrangements.

Authors:  B K Hecht; C Turc-Carel; M Chatel; P Grellier; J Gioanni; R Attias; P Gaudray; F Hecht
Journal:  Cancer Genet Cytogenet       Date:  1995-10-01
View more
  9 in total

1.  Downregulated expression of HSP27 in human low-grade glioma tissues discovered by a quantitative proteomic analysis.

Authors:  Guobo Shen; Shufang Liang; Zhizhong Xu; Liangxue Zhou; Shiyin Xiao; Xiangying Xia; Ronghui Li; Ying Liao; Chao You; Yuquan Wei
Journal:  Proteome Sci       Date:  2010-03-26       Impact factor: 2.480

2.  A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions.

Authors:  Marta M Lipinski; Greg Hoffman; Aylwin Ng; Wen Zhou; Bénédicte F Py; Emily Hsu; Xuxin Liu; Jason Eisenberg; Jun Liu; John Blenis; Ramnik J Xavier; Junying Yuan
Journal:  Dev Cell       Date:  2010-06-15       Impact factor: 12.270

3.  Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation.

Authors:  Cheng-Yi Chang; Chiung-Chyi Shen; Hong-Lin Su; Chun-Jung Chen
Journal:  J Neurooncol       Date:  2011-07-09       Impact factor: 4.130

4.  Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers.

Authors:  Willi Jugel; Stefanie Tietze; Jennifer Daeg; Dietmar Appelhans; Felix Broghammer; Achim Aigner; Michael Karimov; Gabriele Schackert; Achim Temme
Journal:  Cancers (Basel)       Date:  2022-04-11       Impact factor: 6.575

5.  Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1.

Authors:  Tiziana Piepoli; Cemile Jakupoglu; Wenli Gu; Elena Lualdi; Blanca Suarez-Merino; Pietro L Poliani; Maria Grazia Cattaneo; Barbara Ortino; Dorota Goplen; Jian Wang; Rosa Mola; Francesca Inverardi; Carolina Frassoni; Rolf Bjerkvig; Ortrud Steinlein; Lucia M Vicentini; Oliver Brüstle; Gaetano Finocchiaro
Journal:  Neuro Oncol       Date:  2006-03-02       Impact factor: 12.300

6.  Focus on RNA isolation: obtaining RNA for microRNA (miRNA) expression profiling analyses of neural tissue.

Authors:  Wang-Xia Wang; Bernard R Wilfred; Donald A Baldwin; R Benjamin Isett; Na Ren; Arnold Stromberg; Peter T Nelson
Journal:  Biochim Biophys Acta       Date:  2008-02-13

7.  Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes.

Authors:  Wang-Xia Wang; Bernard R Wilfred; Yanling Hu; Arnold J Stromberg; Peter T Nelson
Journal:  RNA       Date:  2009-12-30       Impact factor: 4.942

8.  Inhibition of LRRK2 kinase activity stimulates macroautophagy.

Authors:  Claudia Manzoni; Adamantios Mamais; Sybille Dihanich; Rosella Abeti; Marc P M Soutar; Helene Plun-Favreau; Paola Giunti; Sharon A Tooze; Rina Bandopadhyay; Patrick A Lewis
Journal:  Biochim Biophys Acta       Date:  2013-08-01

9.  Aspirin Induced Glioma Apoptosis through Noxa Upregulation.

Authors:  Cheng-Yi Chang; Ping-Ho Pan; Jian-Ri Li; Yen-Chuan Ou; Jiaan-Der Wang; Su-Lan Liao; Wen-Ying Chen; Wen-Yi Wang; Chun-Jung Chen
Journal:  Int J Mol Sci       Date:  2020-06-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.